
Viking Therapeutics
OrganizationHeard in 12 episodes across 6 shows since Nov 2025
Viking Therapeutics is a clinical-stage biotechnology company developing next-generation therapies for obesity and metabolic diseases. Its pipeline focuses on novel treatments intended to address significant unmet needs in metabolic health.
Episodes
This week
Expert statements
Share of the conversation
Mentions of Viking Therapeutics per 1,000 mentions of anything, 7-day rolling, across the podcasts PodLume Trends follows.
Show the data
| Day | Share (7-day) | Mentions |
|---|---|---|
| Sep 22 | 0.06‰ | 7 |
| Sep 23 | 0.07‰ | 1 |
| Sep 24 | 0.09‰ | 2 |
| Oct 2 | 0.01‰ | 1 |
| Oct 5 | 0.02‰ | 1 |
| Oct 10 | 0.03‰ | 2 |
Email alert
Email me when Viking Therapeutics comes up on a podcast
One email a week at most, with the new episodes that mention Viking Therapeutics. Free, no account needed, unsubscribe in one click.
What experts have said about Viking Therapeutics
6 statements · 5 positive · 1 negative
Viking is not among Matthew’s leading candidates for Lilly acquisition.
“it doesn't seem like Viking would be on my high list”
Open the episode · 118 - End of Week Wrap up - Oct 9, 2026Listen at 11:37
Viking’s results are an optimistic sign for GLP-1 weight-loss maintenance.
“Viking Therapeutics results are really an optimistic sign for that. particular process.”
Open the episode · Viking Soars; On Holding Climbs; Quest Diagnostics DropsListen at 1:26
Viking Therapeutics’ results signal optimism for obesity-drug weight-loss maintenance.
“Viking Therapeutics results are really an optimistic sign for that particular process.”
Open the episode · Viking Soars; On Holding Climbs; Quest Diagnostics DropsListen at 1:28
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Episodes
12 episodes featuring Viking Therapeutics, newest first
- Oct 10, 2026
Biotech ETFs frame a week of company-specific movesBreaking BiotechOct 10, 2026 - Oct 5, 2026
Dollar strength reshapes bets across tech, banks and global marketsCNBC's "Fast Money"Oct 5, 2026 - Oct 2, 2026
Anthropic’s IPO exposes AI’s costly investor dilemmaRich Habits PodcastOct 2, 2026 - Sep 24, 2026
AI optimism lifts Everpure as biotech financing rattles VikingStock MoversSep 24, 2026 - Sep 24, 2026
AI demand lifts Everpure as markets punish weaker forecastsStock MoversSep 24, 2026 - Sep 23, 2026
Trump-Xi summit carries weight beyond concrete dealsWSJ What’s NewsSep 23, 2026